Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16443419 | 0.85 | TGFBR1 (0.33) | POLBTDP1L3MBTL1TGFBR1 | |
| SCHEMBL204127 | 0.79 | TGFBR1 (0.35) | POLBTDP1L3MBTL1TGFBR1KDM4E | |
| SCHEMBL13862886 | 0.79 | TGFBR1 (0.35) | TDP1TGFBR1KDM4EALDH1A1 | |
| SCHEMBL16443543 | 0.79 | GAA (0.34) | POLBTDP1L3MBTL1TGFBR1KDM4E | |
| SCHEMBL16443433 | 0.76 | TGFBR1 (0.33) | TGFBR1ALDH1A1 | |
| SCHEMBL13862863 | 0.76 | TGFBR1 (0.33) | TGFBR1ALDH1A1 | |
| SCHEMBL16443268 | 0.73 | CA2 (0.34) | TGFBR1 | |
| SCHEMBL6240859 | 0.73 | TGFBR1 (0.36) | TDP1TGFBR1KDM4EALDH1A1 | |
| SCHEMBL13862890 | 0.73 | SMN1; SMN2 (0.45) | TDP1L3MBTL1TGFBR1KDM4EALDH1A1 | |
| SCHEMBL3232710 | 0.73 | TGFBR1 (0.36) | TDP1TGFBR1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10087273-B2 | Multifunctional polymers | ISP INVESTMENTS LLC (US) | 2018-10-02 | — | — | US | disclosed |
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | ISP INVESTMENTS INC. (US) | 2015-02-12 | — | — | US | disclosed |
| US-8063245-B2 | Phosphazene compound, photosensitive resin composition and use thereof | KANEKA CORPORATION (JP) | 2011-11-22 | — | — | US | disclosed |
| US-7311950-B2 | Composition, optical compensatory film and liquid crystal display | FUJIFILM CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-7311949-B2 | Composition, optical film, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070289497-A1 | Coating Composition, Optical Film, Anti-reflection Film, Polarizing Plate, and Display Unit Using Them | FUJIFILM CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070098920-A1 | Optical film, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070002232-A1 | Optical compensation film, polarizing plate and liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060142542-A1 | Phosphazene compound, photosensitive resin composition and use thereof | KANEKA CORPORATION (JP) | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | PUF60, PARG, PARN | POLB 550/4885TDP1 2910/4885L3MBTL1 768/4885 |
| US-10087273-B2 | Multifunctional polymers | PUF60, PARG, PARN | POLB 550/4885TDP1 2910/4885L3MBTL1 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.